MSToronto2026 Day Two: What Does the MS Community Need Next?
MSToronto2026 Day Two: What Does the MS Community Need Next?
Tim Coetzee and Pamela Valentine on Day Two at MSToronto2026 – and turning research progress into real-world impact
Today, our special podcast series brings together two major voices from the North American MS community:
🇺🇸 Tim Coetzee, National Multiple Sclerosis Society
🇨🇦 Pamela Valentine, MS Canada
Scientific progress in MS is accelerating. But is that progress reaching the people who need it?
Alongside their reflections on the key takeaways and conversations from Day Two of MSToronto2026, Tim and Pamela join host Brett Drummond to look beyond individual studies and ask some bigger questions about where the MS field goes next.
Where does the MS community need progress most urgently? How can researchers, clinicians, patient organisations and people affected by MS work together more effectively? And how do we make sure scientific advances ultimately translate into meaningful change in people’s lives?
This ECTRIMS podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases. Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.